Sepsis
Typical setting: Pathogen products and cytokines activate monocytes and endothelium.
Widespread tissue-factor expression, anticoagulant failure, and endothelial injury generate systemic thrombin.
DIC module
Follow systemic coagulation activation through microvascular fibrin, factor and platelet consumption, bleeding, organ injury, and trigger-led treatment.
Clinically reviewed by Mark · NMC-registered nurse
Aetiology
Different triggers converge on the condition's central pathological process.
Typical setting: Pathogen products and cytokines activate monocytes and endothelium.
Widespread tissue-factor expression, anticoagulant failure, and endothelial injury generate systemic thrombin.
Typical setting: Extensive tissue damage exposes procoagulants and causes shock.
Tissue factor, hypoperfusion, acidosis, and inflammation destabilise haemostasis.
Typical setting: Placental abruption, amniotic fluid embolism, retained dead fetus, or severe postpartum haemorrhage releases potent procoagulants.
Rapid thrombin generation can consume haemostatic reserves within hours.
Typical setting: Solid tumours and haematological cancers express procoagulant material.
Chronic or acute activation occurs, with APL especially associated with dangerous bleeding.
Typical setting: Pancreatitis, shock, incompatible transfusion, or vascular lesions activate coagulation.
Endothelial injury and circulating procoagulants exceed local regulatory capacity.
Mechanism chain
Follow each link and use it to predict the next clinical consequence.
Inflammation or tissue destruction activates coagulation throughout the circulation.
Natural anticoagulant pathways are overwhelmed or downregulated.
Keep exploring